Neuroprotective effects of group III mGluR in traumatic neuronal injury

Journal of Neurotrauma

Volumn 14, Issue 12, 1997, Pages 885-895

  Faden, Alan I ^a   Ivanova, Svetlana A ^a   Yakovlev, Alexander G ^a   Mukhin, Alexey G ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenylyl cyclase; mRNA; Neurons; NMDA receptor; RT PCR; Tissue culture

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; 8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; ADENYLATE CYCLASE; ALPHA METHYL 2 AMINO 4 PHOSPHONOBUTYRIC ACID; ALPHA METHYL PHOSPHOSERINE; CYCLIC AMP; DIZOCILPINE; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; LACTATE DEHYDROGENASE; MESSENGER RNA; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHOSPHOSERINE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; EMBRYO; ENZYME ACTIVITY; IN VITRO STUDY; NEOCORTEX; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; RAT;

EID: 0031407416     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1997.14.885     Document Type: Article

References (44)

1. AMADOR, E., DORFMAN, L.E., and WACHER, W.E.C. (1963). Serum lactate dehydrogenase activity: An analytical assessment of current assays. Clin. Chem. 9, 391-399.
2. BRUNO, V., SUREDA, F.X., STORTO, M., CASABONO, G., CARUSO, A., KNOPFEL, T., KUHN, R., and NICOLETTI, F. (1997). The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling. J. Neurosci. 17(6), 1891-1897.
3. BRUNO, V., COPANI, A., BONANNO, L., KNOEPFEL, T., KUHN, R., ROBERTS, P.J., and NICOLETTI, F. (1996). Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures. Eur. J. Pharmacol. 310, 61-66.
4. BUISSON, A., and CHOI, D.W. (1995). The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death. Eur. J. Pharmacol. 256, 109-112.
5. BUISSON, A., YU, S.P., and CHOI, D.W. (1996). DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons. Eur. J. Neurol. 8, 138-143.
6. BUSHELL, T.J., JANE, D.E., TSE, H.-W., WATKINS, J.C., DAVIES, C.H., GARTHWAITE, J., and COLLINGRIDGE, G.L. (1995). Antagonism of the synaptic depressant actions of L-AP4 in the lateral perforant path by MAP4. Neuropharmacology 34(2), 239-241.
7. CHIAMULERA, C., ALBERTINI, P., VALERIO, E., and REGGIANI, A. (1992). Activation of metabotropic receptors has a neuroprotective effect in a rodent model of focal ischaemia. Eur. J. Pharmacol. 216, 335-336.
8. CHOI, D.W. (1987). Ion dependence of glutamate neurotoxicity. J. Neurosci. 7, 369-379.
9. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal. Biochem. 162, 156-159.
10. A). Biochem. Pharmacol. 44, 2303-2306.
11. COPANI, A., BRUNO, V., BATTAGLIA, G., LEANZA, G., PELLITTERI, R., RUSSO, A., STANZANI, S., and NICOLETTI, F. (1995). Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by β-amyloid peptide. Mol. Pharmacol. 47, 890-897.
12. FADEN, A.I., and SIMON, R.P. (1988). A potential role for excitotoxins in the pathophysiology of spinal cord injuries. Ann. Neurol. 23, 623-626.
13. FADEN, A.I. (1993). Experimental neurobiology of central nervous system. Crit. Rev. Neurobiol. 7, 175-186.
14. FADEN, A.I., DEMEIUK, P., PANTER, S.S., and VINK, R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 98-800.
15. FITZJOHN, S.M., IRVING, A.J., PALMER, M.J., HARVEY, J., LODGE, D., and COLLINGRIDGE, G.L. (1996). Activation of group I mGluRs potentiates NMDA responses in rat. Neurosci. Lett. 203, 211-213.
16. GONG, Q.Z., DELAHUNTY, T.M., HAMM, R.J., and LYETH, B.G. (1995). Metabotropic glutamate antagonist (MCPG) treatment of traumatic brain injury in rats. Neurosci. Lett. 203, 211-213.
17. HOLLMAN, M., and HEINEMANN, S. (1994). Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108.
18. IVERSEN, L., MULVIHILL, E., HALDEMAN, B., DIEMER, N.H, KAISER, F., SHEARDOWN, M., and KRISTENSEN, P. (1994). Changes in metabotropic glutamate receptor mRNA levels following global ischemia: Increase of a putative presynaptic subtype (mGluR4) in highly vulnerable rat brain areas. J. Neurochem. 63, 625-633.
19. JANE, D.E., JONES, P.L.S.T.J., POOK, P.C.-K., TSE, H.-W., and WATKINS, J.C. (1994). Actions of two antagonists showing selectivity for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord. Br. J. Pharmacol. 112, 809-816.
20. 4a receptor. Eur. J. Pharmacol. (Molecular Pharmacology Section), pp. R1-R3.
21. KNÖPFEL, T., LUKIC, S., LEONARDT, T., FLOR, P.J., KUHN, R., and GASPARINI, F. (1995). Pharmacological characterization of MCCG and MAP4 at the mGluR1b, mGluR2 and mGluR4a human metabotropic glutamate receptor subtypes. Neuropharmacology 34(8), 1099-1102.
22. KRISTENSEN, P., SUZDAK, P.D., and THOMSEN, C. (1993). Expression pattern and pharmacology of the rat type IV metabotropic glutamate receptor. Neurosci. Lett. 155, 159-162.
23. LEVESQUE, A., PAQUET, A., and PAGE, M. (1995). Improved fluorescent bioassay for the detection of tumor necrosis factor activity. J. Immunol. Meth. 178, 71-76.
24. LIPTON, S.A., and ROSENBERG, P.A. (1994). Excitatory amino acids as a final common pathway for neurological disorders. N. Engl. J. Med. 330, 613-622.
25. MAIESE, K., SWIRIDUK, M., and TENBROEKE, M. (1996). Cellular mechanisms of protection by metabotropic glutamate receptors during anoxia and nitric oxide toxicity. J. Neurochem. 66, 2419-2428.
26. MCINTOSH, T.K., VINK, R., SOARES, H., HAYES, R., and SIMON, R. (1990). Effect of noncompetitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury. J. Neurochem. 55, 1170-1179.
27. MUKHIN, A., FAN, L., and FADEN, A.I. (1996). Activation of metabotropic glutamate receptor subtype mGluR1 contributes to post-traumatic neuronal injury. J. Neurosci. 16, 6012-6020.
28. MUKHIN, A.G., IVANOVA, S.A., KNOBLACH, S.M., and FADEN, A.I. (1997a). New in vitro model of traumatic neuronal injury: Evaluation of secondary injury and glutamate receptor mediated neurotoxicity. J. Neurotrauma 14, 651-663.
29. MUKHIN, A.G., IVANOVA, S.A., and FADEN, A.I. (1997b). mGluR modulation of post-traumatic neuronal death: Role of NMDA receptors. NeuroReport 8, 2561-2566.
30. NAKAJIMA, Y., IWAKABE, H., AKAZAWA, C., NAWA, H., SHIGEMOTO, R., and NAKANSHI, S. (1993). Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for 1-2-amino-4-phosphonobutyrate. J. Biol. Chem. 268, 11868-11873.
31. NAWY, S., and JAHR, C.E. (1990). Suppression by glutamate of cGMP-activated conductance in retina bipolar cells. Nature 346, 269-271.
32. NILSSON, P., HILLERED, L., PONTE, U., and UNGERSTEDT, U. (1990). Changes in conical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J. Cereb. Blood Flow Metab. 10, 631.
33. PANTER, S.S., YUM, S.W., and FADEN, A.I. (1990). Alterations in extracellular amino acids after traumatic spinal cord injury. Ann. Neurol. 27, 96-99.
34. PANTER, S.S., and FADEN, A.I. (1994). Biochemical changes and secondary injury from stroke and trauma, in: Principles and Practice of Restorative Neurology. R.R. Young and P.J. Delawade (eds), Butterworth: New York, pp. 32-52.
35. PIN, J.-P., and DUVOISIN, R. (1995). Review: Neurotransmitter receptors I - The metabotropic glutamate receptors: Structure and functions. Neuropharm. 34, 1-26.
36. REGAN, R.F., and CHOI, D.W. (1994a). Excitotoxicity and central nervous system trauma, in: The Neurobiology of Central Nervous System Trauma. S.K. Salzman, and A.I. Faden, eds), pp. 173-181.
37. REGAN, R.F., and CHOI, D.W. (1994b). The effect of NMDA, AMPA-kainate, and calcium channel antagonist on traumatic cortical neuronal injury in culture. Brain Res. 633, 236-242.
38. SANDBERG, M., BUTT, E., NOLTE, C., FISCHER, L., HALBRUGGE, M., BELTMAN, J., JAHNSEN, T., GENIESTER, H.G., JASTORFF, B., and WALTER, U. (1991). Characterization of Sp-5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole-3′,5′- monophosphorothioate (Sp-5,6-DC1-cBiMPS) as a potent and specific activator of cAMP-dependent protein kinase in cell extracts and intact cells. Biochem J. 279, 521-527.
39. SHEIELLS, R.A., and FALK, G. (1990). Glutamate receptors of rod bipolar cells are linked to a cyclic GMP cascade via a G-protein. Proc. R. Soc. Lond. Biol. 242, 91-94.
40. THOMAS, N.K., JANE, D.E., TSE, H.-W., and WATKINS, J.C. (1996). a-methyl derivatives of serine-O-phosphate as novel, selective competitive metabotropic glutamate receptor antagonists. Neuropharmacology 35, 637-642.
41. WATKINS, J., and COLLINGRIDGE, G. (1994). Review: Phenylglycine derivatives as antagonists of metabotropic receptors. Trends Pharmacol. Sci. 15, 333-342.
42. WRATHALL, J.R., TENG, Y.D., CHOINIERE, D., and MUNDT, D.J. (1992). Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury. Brain Res. 586, 140-143.
43. WROBLEWSKI, J.T., PSHENICHKIN, S., and WROBLEWSKA, B. (1996). Pharmacological characterization of mGluR6 metabotropic glutamate receptors expressed in CHO cells. Soc. Neurosci. Abstr. 22, 808.
44. YAKOVLEV, A.G., and FADEN, A.I. (1995). Molecular strategies in CNS injury. J. Neurotrauma 12, 767-777.